Co-Diagnostics, Inc. 0A50.L Stock
Co-Diagnostics, Inc. Price Chart
Co-Diagnostics, Inc. 0A50.L Financial and Trading Overview
| Co-Diagnostics, Inc. stock price | 1.5 USD |
| Previous Close | 1.08 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 6.96 USD |
| Volume | 6.47K USD |
| Avg. Volume | 705 USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | -0.645422 |
| PE Ratio (TTM) | 0.007926829 |
| EPS (TTM) | 1.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0A50.L Valuation Measures
| Enterprise Value | -42870412 USD |
| Trailing P/E | 0.007926829 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.28792912 |
| Enterprise Value/Revenue | -3.537 |
| Enterprise Value/EBITDA | 1.428 |
Trading Information
Co-Diagnostics, Inc. Stock Price History
| Beta (5Y Monthly) | -0.645422 |
| 52-Week Change | -79.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.96 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 2.17 USD |
| 200-Day Moving Average | 3.41 USD |
0A50.L Share Statistics
| Avg. Volume (3 month) | 705 USD |
| Avg. Daily Volume (10-Days) | 728 USD |
| Shares Outstanding | N/A |
| Float | 29.73M |
| Short Ratio | N/A |
| % Held by Insiders | 1.07% |
| % Held by Institutions | 19.42% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -261.59% |
| Operating Margin (ttm) | -258.77% |
| Gross Margin | 77.71% |
| EBITDA Margin | -247.62% |
Management Effectiveness
| Return on Assets (ttm) | -13.60% |
| Return on Equity (ttm) | -24.54% |
Income Statement
| Revenue (ttm) | 12.12M USD |
| Revenue Per Share (ttm) | 0.4 USD |
| Quarterly Revenue Growth (yoy) | -97.29% |
| Gross Profit (ttm) | 28.74M USD |
| EBITDA | -30014636 USD |
| Net Income Avi to Common (ttm) | -31708236 USD |
| Diluted EPS (ttm) | 1.312 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 75.28M USD |
| Total Cash Per Share (mrq) | 2.49 USD |
| Total Debt (mrq) | 935.43K USD |
| Total Debt/Equity (mrq) | 0.85 USD |
| Current Ratio (mrq) | 23.801 |
| Book Value Per Share (mrq) | 3.612 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6736536 USD |
| Levered Free Cash Flow (ttm) | -3256899 USD |
Profile of Co-Diagnostics, Inc.
| Country | United Kingdom |
| State | UT |
| City | Salt Lake City |
| Address | 2401 South Foothill Drive |
| ZIP | 84109 |
| Phone | 801 438 1036 |
| Website | https://www.codiagnostics.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 145 |
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Q&A For Co-Diagnostics, Inc. Stock
What is a current 0A50.L stock price?
Co-Diagnostics, Inc. 0A50.L stock price today per share is 1.5 USD.
How to purchase Co-Diagnostics, Inc. stock?
You can buy 0A50.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Co-Diagnostics, Inc.?
The stock symbol or ticker of Co-Diagnostics, Inc. is 0A50.L.
How many shares does Co-Diagnostics, Inc. have in circulation?
The max supply of Co-Diagnostics, Inc. shares is 0.
What is Co-Diagnostics, Inc. Price to Earnings Ratio (PE Ratio)?
Co-Diagnostics, Inc. PE Ratio is 1.13996950 now.
What was Co-Diagnostics, Inc. earnings per share over the trailing 12 months (TTM)?
Co-Diagnostics, Inc. EPS is 1.31 USD over the trailing 12 months.